We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

3 hedge funds and large institutions have $133K invested in GlucoTrack in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more capital invested

Capital invested by funds: $60.2K → $133K (+$72.5K)

50% more funds holding

Funds holding: 2 → 3 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$72.9K

Top Sellers

No sellers this quarter

GCTK Hedge Fund Activity: Q3 2024 in Review

3 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q3 2024, worth a combined $133K — up 120% from $60.2K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new GCTK positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $72.9K.

  • 3 institutional investors held GlucoTrack (GCTK) as of Q3 2024, up from 2 in Q2 2024.
  • Funds reported $133K of GlucoTrack stock for Q3 2024, up 120% quarter-over-quarter.
  • 1 fund opened new GlucoTrack positions in Q3 2024 and 0 closed out, a net change of +1 holder.
  • The largest GlucoTrack buyer in Q3 2024 was Geode Capital Management, an estimated $72.9K added.

Based on aggregated 13F filings for Q3 2024.